Growth Metrics

Omeros (OMER) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 33.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -154.28%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.53%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 52.13%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 52.13%
Dec 31, 2025 57.10%
Sep 30, 2025 17.37%
Jun 30, 2025 6.24%
Mar 31, 2025 -0.45%
Dec 31, 2024 -26.79%
Sep 30, 2024 5.71%
Jun 30, 2024 -25.15%
Mar 31, 2024 -1.95%
Dec 31, 2023 -1.77%
Sep 30, 2023 0.62%
Jun 30, 2023 -3.85%
Mar 31, 2023 -5.10%
Dec 31, 2022 -16.36%
Sep 30, 2022 -49.30%
Jun 30, 2022 -28.75%
Mar 31, 2022 -10.68%
Dec 31, 2021 140.58%
Sep 30, 2021 -3.90%
Jun 30, 2021 5.33%
Mar 31, 2021 -5.30%
Dec 31, 2020 -31.08%
Sep 30, 2020 -72.59%
Jun 30, 2020 -32.36%
Mar 31, 2020 -24.38%
Dec 31, 2019 -14.18%
Sep 30, 2019 -5.65%
Jun 30, 2019 -4.65%
Mar 31, 2019 -5.83%
Dec 31, 2018 -5.88%
Sep 30, 2018 -25.60%
Jun 30, 2018 -26.41%
Mar 31, 2018 -17.20%
Dec 31, 2017 7.20%
Sep 30, 2017 25.82%
Jun 30, 2017 7.24%
Mar 31, 2017 3.21%
Dec 31, 2016 -119.95%
Sep 30, 2016 -0.22%
Jun 30, 2016 2.46%
Mar 31, 2016 -25.11%
Dec 31, 2015 -36.86%
Sep 30, 2015 -14.48%
Jun 30, 2015 -25.01%
Mar 31, 2015 -28.03%
Dec 31, 2014 -26.63%
Sep 30, 2014 -41.19%
Jun 30, 2014 -50.37%
Mar 31, 2014 -36.51%
Dec 31, 2013 36.57%
Sep 30, 2013 -22.45%
Jun 30, 2013 -20.32%